These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 4088901)

  • 1. [Results of hormone and chemotherapy of patients with cancer of the corpus uteri].
    Ploch E
    Nowotwory; 1985; 35(3):255-61. PubMed ID: 4088901
    [No Abstract]   [Full Text] [Related]  

  • 2. Melphalan, 5-fluorouracil, and medroxyprogesterone acetate in metastatic endometrial carcinoma.
    Piver MS; Lele SB; Patsner B; Emrich LJ
    Obstet Gynecol; 1986 Feb; 67(2):261-4. PubMed ID: 3945437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination chemotherapy for advanced endometrial cancer. An evaluation of three regimens.
    Horton J; Elson P; Gordon P; Hahn R; Creech R
    Cancer; 1982 Jun; 49(12):2441-5. PubMed ID: 7074558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Successful treatment of advanced endometrial carcinoma with pleural effusion due to cancer by cisplatin, doxorubicin, and medroxyprogesterone acetate].
    Hayashi Y; Hachisuga M; Tateyama H
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Jul; 39(7):1173-6. PubMed ID: 3611885
    [No Abstract]   [Full Text] [Related]  

  • 5. [Combination with medroxyprogesterone acetate and chemotherapy making possible complete removal of uterine corpus carcinoma].
    Tajima H; Okada T; Fujimori Y; Tomioka Y; Hirano M; Yoshida T; Ikeda S; Hata T
    Gan To Kagaku Ryoho; 1989 Jul; 16(7):2461-4. PubMed ID: 2526620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of advanced endometrial adenocarcinoma with cyclic sequential ethinyl estradiol and medroxyprogesterone acetate.
    Tatman JL; Freedman RS; Scott W; Atkinson EN
    Eur J Cancer Clin Oncol; 1989 Nov; 25(11):1619-21. PubMed ID: 2531671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative evaluation of the effectiveness of induction chemotherapy using the Cooper, FAC and FAC + MPA protocols in patients with locally advanced breast cancer].
    Pawlicki M; Brandys A; Zuchowska B
    Nowotwory; 1986; 36(2):124-9. PubMed ID: 2947046
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical efficacy of ifosfamide for liver metastasis of breast cancer].
    Funahashi H; Sato Y; Imai T; Kato N; Ando K; Oike E; Odaka K; Ono M; Narita T; Kato M
    Gan To Kagaku Ryoho; 1990 Apr; 17(4 Pt 1):689-92. PubMed ID: 2157371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ifosfamide, cisplatin, adriamycin combination chemotherapy in gynecologic cancer].
    Sawada M; Inagaki M; Hirota Y; Hongo J; Ozaki M
    Gan To Kagaku Ryoho; 1987 Nov; 14(11):3091-4. PubMed ID: 3674894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant therapy in primary breast cancer.
    Wolmark N; Fisher B
    Surg Clin North Am; 1985 Feb; 65(1):161-80. PubMed ID: 3887616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant chemotherapy in stage II breast cancer: a brief overview of the NSABP clinical trials.
    Wolmark N; Fisher B
    World J Surg; 1985 Oct; 9(5):699-706. PubMed ID: 2856855
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of recurrent or metastatic poorly differentiated adenocarcinoma of the endometrium with tamoxifen and medroxyprogesterone acetate.
    Kline RC; Freedman RS; Jones LA; Atkinson EN
    Cancer Treat Rep; 1987 Mar; 71(3):327-8. PubMed ID: 2949831
    [No Abstract]   [Full Text] [Related]  

  • 13. Combination chemotherapy of breast cancer.
    Cooper RG
    Mt Sinai J Med; 1985 Jun; 52(6):443-6. PubMed ID: 3875023
    [No Abstract]   [Full Text] [Related]  

  • 14. Postoperative chemotherapy and tamoxifen compared with tamoxifen alone in the treatment of positive-node breast cancer patients aged 50 years and older with tumors responsive to tamoxifen: results from the National Surgical Adjuvant Breast and Bowel Project B-16.
    Fisher B; Redmond C; Legault-Poisson S; Dimitrov NV; Brown AM; Wickerham DL; Wolmark N; Margolese RG; Bowman D; Glass AG
    J Clin Oncol; 1990 Jun; 8(6):1005-18. PubMed ID: 2189950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of sequential cyclical hormonal therapy in endometrial cancer and its correlation with steroid hormone receptor status.
    Ayoub J; Audet-Lapointe P; Méthot Y; Hanley J; Beaulieu R; Chemaly R; Cormier A; Déry JP; Drouin P; Gauthier P
    Gynecol Oncol; 1988 Oct; 31(2):327-37. PubMed ID: 2971597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uterine mullerian adenosarcoma following adenomyoma in a woman on tamoxifen therapy.
    Bocklage T; Lee KR; Belinson JL
    Gynecol Oncol; 1992 Jan; 44(1):104-9. PubMed ID: 1309716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant therapy for breast cancer: a brief overview of the NSABP experience and some thoughts on neoadjuvant chemotherapy.
    Fisher B
    Recent Results Cancer Res; 1986; 103():54-68. PubMed ID: 3526476
    [No Abstract]   [Full Text] [Related]  

  • 18. Chemotherapy of ovarian cancer.
    Ozols RF; Young RC
    Semin Oncol; 1984 Sep; 11(3):251-63. PubMed ID: 6435250
    [No Abstract]   [Full Text] [Related]  

  • 19. [Efficacy of implantable injection port for advanced breast cancer patients].
    Nakamura S; Itoh M; Ohigashi S; Nishio T; Abe O; Sakurai K
    Gan To Kagaku Ryoho; 1996 Sep; 23(11):1529-32. PubMed ID: 8854798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doxorubicin-containing regimens for the treatment of stage II breast cancer: The National Surgical Adjuvant Breast and Bowel Project experience.
    Fisher B; Redmond C; Wickerham DL; Bowman D; Schipper H; Wolmark N; Sass R; Fisher ER; Jochimsen P; Legault-Poisson S
    J Clin Oncol; 1989 May; 7(5):572-82. PubMed ID: 2651576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.